Sunshine Biopharma (SBFMW) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Sunshine Biopharma (SBFMW) over the last 8 years, with Q3 2025 value amounting to $636708.0.
- Sunshine Biopharma's Total Non-Current Liabilities rose 3019.89% to $636708.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $636708.0, marking a year-over-year increase of 3019.89%. This contributed to the annual value of $744724.0 for FY2024, which is 2670.46% up from last year.
- Sunshine Biopharma's Total Non-Current Liabilities amounted to $636708.0 in Q3 2025, which was up 3019.89% from $706530.0 recorded in Q2 2025.
- Sunshine Biopharma's 5-year Total Non-Current Liabilities high stood at $744724.0 for Q4 2024, and its period low was $489027.0 during Q3 2024.
- Moreover, its 4-year median value for Total Non-Current Liabilities was $638295.0 (2023), whereas its average is $627026.4.
- Per our database at Business Quant, Sunshine Biopharma's Total Non-Current Liabilities crashed by 2004.23% in 2024 and then surged by 3809.26% in 2025.
- Sunshine Biopharma's Total Non-Current Liabilities (Quarter) stood at $685264.0 in 2022, then decreased by 14.23% to $587764.0 in 2023, then rose by 26.7% to $744724.0 in 2024, then decreased by 14.5% to $636708.0 in 2025.
- Its last three reported values are $636708.0 in Q3 2025, $706530.0 for Q2 2025, and $722199.0 during Q1 2025.